π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Betw...
Status
Unknown
Location
Lexicon Investigational Site
Start Date
2015-07
Trial ID
NCT02494609
Treatments Being Tested
The purpose of this study is to evaluate effect of moxifloxacin on QT/QTc i...
Status
Completed
Location
Seoul National University Hospital
Start Date
2013-01
Trial ID
NCT01756521
Treatments Being Tested
Traditional management of community-acquired pneumonia (CAP) relies on the ...
Status
Completed
Location
4th Department of Internal Medicine, Attikon University Hospital
Start Date
2021-01-25
Trial ID
NCT04724044
Treatments Being Tested
The purpose of this study is to demonstrate a lack of effect of venlafaxine...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-12
Trial ID
NCT02637193
Treatments Being Tested
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00876850
The purpose of this study was to compare the effects of Vigamox and Cravit ...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00840580
The purpose of the study is to determine whether Moxidex ophthalmic solutio...
Status
Terminated
Location
Contact Alcon Call Center at 1-888-451-3937
Start Date
2007-12
Trial ID
NCT00579020
The purpose of this study is to determine the pharmacokinetics (how a drug ...
Status
Terminated
Location
Johns Hopkins University
Start Date
2007-06
Trial ID
NCT00460759
Treatments Being Tested
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
A single-center, randomized, double-blinded, 2-way crossover, placebo-contr...
Status
Unknown
Location
Peking University Third Hospital Drug Clinical Trial Center
Start Date
2012-07
Trial ID
NCT01653990
Treatments Being Tested